Acute promyelocytic leukemia: from genetics to treatment.
Grignani
F
F
Istituto di Clinica Medica I, University of Perugia, Policlinico Monteluce, Italy.
Fagioli
M
M
Alcalay
M
M
Longo
L
L
Pandolfi
P P
PP
Donti
E
E
Biondi
A
A
Lo Coco
F
F
Grignani
F
F
Pelicci
P G
PG
D002454:Cell Differentiation; D006412:Hematopoietic Stem Cells / Q000502:physiology; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy / Q000235:genetics*; D009363:Neoplasm Proteins; D009687:Nuclear Proteins; D000071156:Promyelocytic Leukemia Protein; D018168:Receptors, Retinoic Acid / Q000737:chemistry / Q000502:physiology*; D014157:Transcription Factors / Q000737:chemistry / Q000502:physiology*; D014178:Translocation, Genetic; D014212:Tretinoin / Q000009:adverse effects / Q000627:therapeutic use*; D025521:Tumor Suppressor Proteins
D009363:Neoplasm Proteins; D009687:Nuclear Proteins; D000071156:Promyelocytic Leukemia Protein; D018168:Receptors, Retinoic Acid; D014157:Transcription Factors; D025521:Tumor Suppressor Proteins; C070576:PML protein, human; D014212:Tretinoin